Literature DB >> 29131050

The Clinical Inadequacy of the Placebo Model and the Development of an Alternative Conceptual Framework.

Giovanni A Fava1, Jenny Guidi, Chiara Rafanelli, Karl Rickels.   

Abstract

Placebo effects are often attributed to clinical interactions and contextual factors that affect expectations of the patient about the treatment and result in symptom changes. The prevailing conceptualization consists of an undifferentiated placebo response that needs to be minimized in controlled investigations and maximized in clinical practice. However, treatment outcome is the cumulative result of the interaction of several classes of variables with a selected treatment: living conditions (housing, nutrition, work environment, social support), patient characteristics (age, sex, genetics, general health conditions, personality, well-being), illness features and previous therapeutic experience, self-management, and treatment setting (physician's attitude and attention, illness behavior). Such variables may be therapeutic or countertherapeutic, and are unlikely to be simply additive. In certain patients their interactive combination may lead to clinical improvement, whereas in other cases it may produce no effect, and, in a third group, it may lead to worsening of the condition. Maximizing patients' expectations does not necessarily result in sustained effects and, in due course, may actually lead to worsening of the condition (violation of expectations). In this paper, we outline a multifactorial conceptual model that may have implications for the design of clinical trials as well as for clinical practice, with special reference to psychopharmacology and psychotherapy. The effects of drug treatment may be potentiated by specific nonpharmacological treatment strategies, and this synergism may disclose significant differences against placebo. Medical outcomes may be unsatisfactory not because technical interventions are missing, but because our conceptual models and thinking are inadequate.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Drug treatment; Evidence-based medicine; Illness behavior; Placebo; Psychotherapy; Self-management; Tolerance; Treatment setting

Mesh:

Year:  2017        PMID: 29131050     DOI: 10.1159/000480038

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  11 in total

1.  What matters more? Common or specific factors in cognitive behavioral therapy for OCD: Therapeutic alliance and expectations as predictors of treatment outcome.

Authors:  Asher Y Strauss; Jonathan D Huppert; H Blair Simpson; Edna B Foa
Journal:  Behav Res Ther       Date:  2018-03-27

2.  Prior Therapeutic Experiences, Not Expectation Ratings, Predict Placebo Effects: An Experimental Study in Chronic Pain and Healthy Participants.

Authors:  Luana Colloca; Titilola Akintola; Nathaniel R Haycock; Maxie Blasini; Sharon Thomas; Jane Phillips; Nicole Corsi; Lieven A Schenk; Yang Wang
Journal:  Psychother Psychosom       Date:  2020-06-03       Impact factor: 17.659

3.  Are Conditioned Open Placebos Feasible as an Adjunctive Treatment to Opioids? Results from a Single-Group Dose-Extender Pilot Study with Acute Pain Patients.

Authors:  Michael H Bernstein; Molly Magill; Arnold-Peter Weiss; Ted J Kaptchuk; Charlotte Blease; Irving Kirsch; Josiah D Rich; Sara J Becker; Steven Mach; Francesca L Beaudoin
Journal:  Psychother Psychosom       Date:  2019-09-27       Impact factor: 17.659

4.  Enhancing Cognitive Restructuring with Concurrent Repetitive Transcranial Magnetic Stimulation: A Transdiagnostic Randomized Controlled Trial.

Authors:  Andrada D Neacsiu; Lysianne Beynel; John P Powers; Steven T Szabo; Lawrence G Appelbaum; Sarah H Lisanby; Kevin S LaBar
Journal:  Psychother Psychosom       Date:  2021-09-22       Impact factor: 17.659

Review 5.  Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies.

Authors:  Flavia Franconi; Ilaria Campesi; Delia Colombo; Paola Antonini
Journal:  Cells       Date:  2019-05-17       Impact factor: 6.600

6.  Significance of Participants' Expectations in Managing the Placebo Effect in Antidepressant Research.

Authors:  Marko Curkovic; Andro Kosec
Journal:  Front Psychiatry       Date:  2019-10-01       Impact factor: 4.157

7.  Protocol on transcranial alternating current stimulation for the treatment of major depressive disorder: a randomized controlled trial.

Authors:  Hong-Xing Wang; Kun Wang; Wen-Rui Zhang; Wen-Feng Zhao; Xiao-Tong Yang; Li Wang; Mao Peng; Zhi-Chao Sun; Qing Xue; Yu Jia; Ning Li; Kai Dong; Qian Zhang; Shu-Qin Zhan; Bao-Quan Min; Chun-Qiu Fan; Ai-Hong Zhou; Hai-Qing Song; Lu Yin; Tian-Mei Si; Jing Huang; Jie Lu; Hai-Xia Leng; Wei-Jun Ding; Yuan Liu; Tian-Yi Yan; Yu-Ping Wang
Journal:  Chin Med J (Engl)       Date:  2020-01-05       Impact factor: 2.628

8.  A virtual experimenter does not increase placebo hypoalgesia when delivering an interactive expectancy manipulation.

Authors:  Bjoern Horing; Sarah C Beadle; Zachariah Inks; Andrew Robb; Eric R Muth; Sabarish V Babu
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

9.  Association of nocebo hyperalgesia and basic somatosensory characteristics in a large cohort.

Authors:  Mari Hanna Feldhaus; Björn Horing; Christian Sprenger; Christian Büchel
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

10.  Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.

Authors:  Andrea W M Evers; Luana Colloca; Charlotte Blease; Marco Annoni; Lauren Y Atlas; Fabrizio Benedetti; Ulrike Bingel; Christian Büchel; Claudia Carvalho; Ben Colagiuri; Alia J Crum; Paul Enck; Jens Gaab; Andrew L Geers; Jeremy Howick; Karin B Jensen; Irving Kirsch; Karin Meissner; Vitaly Napadow; Kaya J Peerdeman; Amir Raz; Winfried Rief; Lene Vase; Tor D Wager; Bruce E Wampold; Katja Weimer; Katja Wiech; Ted J Kaptchuk; Regine Klinger; John M Kelley
Journal:  Psychother Psychosom       Date:  2018-06-12       Impact factor: 17.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.